Merck & Co – known as MSD outside the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has ...

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Merck ( MRK) is a global biopharmaceutical giant with a diversified portfolio that spans across oncology, vaccines, ...

The recent experience of Chinese biotech companies in developing their own drug candidates and inking deals with larger ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...